(Q38969062)

8 September 2017

1 reference

title

Calcium phosphate: a substitute for aluminum adjuvants? (English)

1 reference

8 September 2017

0 references

Guillemette Crépeaux

4

0 references

author name string

Jean-Daniel Masson

series ordinal

1

1 reference

8 September 2017

Michel Thibaudon

series ordinal

2

1 reference

8 September 2017

Laurent Bélec

series ordinal

3

1 reference

8 September 2017

publication date

3 October 2016

1 reference

Expert Review of Vaccines

8 September 2017

published in

1 reference

8 September 2017

volume

16

1 reference

8 September 2017

issue

3

1 reference

8 September 2017

page(s)

289-299

1 reference

Aluminum vaccine adjuvants: are they safe?

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Macrophagic myofasciitis: an emerging entity. Groupe d'Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Française contre les Myopathies (AFM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Human exposure to aluminium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Why industry propaganda and political interference cannot disguise the inevitable role played by human exposure to aluminum in neurodegenerative diseases, including Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

What is the risk of aluminium as a neurotoxin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

New adjuvants: EU regulatory developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Antibody response of pregnant women to two different absorbed tetanus toxoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Aluminium compounds for use in vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Adjuvanticity of aluminium hydroxide and calcium phosphate in diphtheria-tetanus vaccines--I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Effect of the particle size on the micro and nanostructural features of a calcium phosphate cement: a kinetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Comparison of the adjuvant activity of aluminum hydroxide and calcium phosphate on the antibody response towards Bothrops asper snake venom

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Particulate adjuvant and innate immunity: past achievements, present findings, and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

21 January 2018

Nanoparticle vaccines

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

The impact of size on particulate vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Systemic antibody response to nano-size calcium phospate biocompatible adjuvant adsorbed HEV-71 killed vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Adjuvants--a balance between toxicity and adjuvanticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Mode of action of adjuvants: implications for vaccine safety and design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Aluminium phosphate but not calcium phosphate stimulates the specific IgE response in guinea pigs to tetanus toxoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Vaccine adjuvants: current state and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Biological and medical significance of calcium phosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Biopersistence and brain translocation of aluminum adjuvants of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Applying biodegradable particles to enhance cancer vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Studies on the toxicities of aluminium hydroxide and calcium phosphate as immunological adjuvants for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

The use of size-defined DNA-functionalized calcium phosphate nanoparticles to minimise intracellular calcium disturbance during transfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Formulation of Newcastle disease virus coupled calcium phosphate nanoparticles: an effective strategy for oculonasal delivery to chicken

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Towards an understanding of the adjuvant action of aluminium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Rod-shaped and substituted hydroxyapatite nanoparticles stimulating type 1 and 2 cytokine secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Rod-shaped and fluorine-substituted hydroxyapatite free of molecular immunopotentiators stimulates anti-cancer immunity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

The type of adjuvant strongly influences the T-cell response during nanoparticle-based immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Just-in-time vaccines: Biomineralized calcium phosphate core-immunogen shell nanoparticles induce long-lasting CD8(+) T cell responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Protein coated microcrystals formulated with model antigens and modified with calcium phosphate exhibit enhanced phagocytosis and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Photophysics of Cy3-encapsulated calcium phosphate nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Mesoporous silica-calcium phosphate-tuberculin purified protein derivative composites as an effective adjuvant for cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Zn- and Mg- containing tricalcium phosphates-based adjuvants for cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

Optimization of physiological properties of hydroxyapatite as a vaccine adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2017.1244484

10.1080/14760584.2017.1244484

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference